Table 1 Characteristics of study participants and their infants
From: Antibodies in the breastmilk of COVID-19 recovered women
Feature | Study Group n = 72 | Control Group n = 17 | p value |
|---|---|---|---|
Age (years) | 32.5 ± 3.8 | 34.4 ± 4.2 | 0.082 |
(32, 30-35) | (33, 32-37) | ||
Gravida | 0.701 | ||
1 | 34 (47.2%) | 7 (41.2%) | |
2 | 30 (41.7%) | 6 (35.3%) | |
≥ 3 | 8 (11.1%) | 3 (17.6%) | |
Body Mass Index (kg/m2) | 25.22 ± 3.83 (24.7, 22.8-27.6) | 24.89 ± 3.86 (24.2, 22.1-28.4) | 0.734 |
Pre-existing comorbidities | 27 (37.5%) | 5 (29.4%) | 0.532 |
Pregnancy morbidities | 38 (52.8%) | 9 (52.9%) | 0.535 |
Mode of Delivery | 0.344 | ||
vaginal | 25 (34.7%) | 8 (47.1%) | |
caesarean section | 47 (65.3%) | 9 (52.9%) | |
History of miscarriage prior to the current pregnancy | 22 (30.6%) | 5 (29.4%) | .927 |
Gestational age at birth (weeks) | 37.9 ± 2.9 | 37.6 ± 4.0 | 0.804 |
(39, 37-40) | (39, 38-40) | ||
Preterm birth | 17 (23.6%) | 3 (17.6%) | 0.596 |
Child gender (F/M) | 33 (45.8%) / 39 (54.2%) | 7 (41.2%) / 10 (58.8%) | 0.7292 |
Child weight (g) | 3233.7 ± 675.6 | 3291.9 ± 1174.8 | 0.208 |
(3360, 2950-3700) | (3530, 3100-4140) | ||
Child length (cm) | 51.3 ± 5.7 | 53.8 ± 7.6 | 0.007 |
(52, 51-54) | (55, 53-58) | ||
Apgar score | |||
≥ 37 weeks of GA | |||
1’ | 10, 9-10 | 10, 10-10 | 0.117 |
5’ | 10, 10-10 | 10, 10-10 | 0.298 |
< 37 weeks of GA | |||
1’ | 8, 7-9 | Data missed | |
5’ | 9, 8-10 | Data missed | |
Breastfeeding status | 0.108 | ||
Only breast | 41 (56.9%) | 6 (35.3%) | |
Mixed | 31 (43.1%) | 11 (64.7%) | |
Symptoms of COVID-19 | 62 (86.1%) | 0 (100%) | < 0.001 |